Skip to main navigation Skip to search Skip to main content

Immunopathology of rsv: An updated review

  • Harrison C. Bergeron
  • , Ralph A. Tripp

Research output: Contribution to journalReview articlepeer-review

174 Downloads (Pure)

Abstract

RSV is a leading cause of respiratory tract disease in infants and the elderly. RSV has limited therapeutic interventions and no FDA-approved vaccine. Gaps in our understanding of virus–host interactions and immunity contribute to the lack of biological countermeasures. This review updates the current understanding of RSV immunity and immunopathology with a focus on interferon responses, animal modeling, and correlates of protection.

Original languageEnglish
Article number2478
Pages (from-to)1-30
Number of pages30
JournalViruses
Volume13
Issue number12
DOIs
Publication statusPublished - Dec 2021
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Immunopathology of rsv: An updated review'. Together they form a unique fingerprint.

Cite this